Tukei P M
Kenya Medical Research Institute.
Afr J Health Sci. 1996 Aug;3(3):65.
In May l988, the Annual Meeting of the World Health Assembly (WHA) committed WHO to the exciting challenge of Global Eradication of Poliomyelitis by the year 2000. The World accepted this challenge based on a number of scientific factors that had already been witnessed and certain other basic epidemiological factors concerning the transmission of the wild polio virus: 1. Smallpox had been eradicated and the global machinery and commitment for repeating such a feat could still be mobilised on She same lines to tackle another global menace; 2. The Pan American Health Organisation (PAHO) had already by May 1985 committed the American region to polio eradication by the year 1990. Although many people were initially sceptical of this initiative, it was quickly realised and recorded that the programme mounted by PAHO was achieving a high level of success and the goal of eradication was achievable; 3. Epidemiological! transmission factors that are persuasive to science for mounting eradication initiatives include: a) The wild polio virus moves from man to man only and has no wild animal reservoir to maintain it. b) An infected individual either dies, is crippled or fully recovers and remains immune without retaining or carrying the virus for many years (no carrier state) c) Available vaccine, particularly the oral (OPV) is not only capable of inducing long standing immunity in an individual but can, by multiplying in the gut, exclude or interrupt the circulation of the wild strain. The basic concepts and strategies for polio eradication recommended by WHO and now adapted globally are quite simple: 1. For each national expanded programme on immunisation (EPI) to raise the primary polio coverage rate with OPV to beyond 80% as a routine in children under one year. Under such conditions of immunisation in every locality in every district and province, the incidence of paralytic polio is quickly reduced to very low levels. Most countries in the world have already achieved and exceeded this level of coverage. 2. For each country to conduct National Immunisation Days (NIDs) daring which 2 doses of OPV, one month apart, are administered to ALL children under 5 years of age irrespective of their previous vaccination status. This strategy boosts the immunity in (he children already vaccinated and catches those missed by routine services. The wild polio virus cannot live for long periods outside the human body, hence the NIDs effectively remove the wild polio virus from circulation. China was able to vaccinate over SO million children under 5ysars with OPV within two days. Currently the practice is for many neighbouring countries (even upto 15 at a time) to simultaneously operationalise their NIDs on 2 to 3 days. 3. For each country to establish and operate an extremely sensitive surveillance system capable of detecting any new case of acute flaccid paralysis (AFP), Since paralysis can be produced by other conditions, it is necessary to back up the field surveillance with a reliable laboratory service capable of isolating poliovirus from the stool samples of paralytic cases. An isolated poliovirus would then have to be typed as wild or vaccine type strain. The strategies described above have all beers activated in all countries of the world and the world is already1 witnessing a dramatic disappearance of new cases of AFF. The International Certification Commission on Polio Eradication has established formal criteria by which countries can be certified polio-free. A polio-free status has to be maintained for at least 3 years in the countries of a region for that region to be certified as having eradicated the wild poliovirus. Global eradication will have been achieved if and when all regions in the world have been certified. The world is, no doubt, most grateful to all those international organisations, such as the Rotary International, WHO, UNICEF, national governments of the developed world through! donor agencies such as J1CA, US AID, D ANID A, etc., for the enormous resources that have been mobilised to operationalise EPI programmes for polio eradication. This gratitude is also a tribute in the late Dr. Albert Sabin, the discoverer of the oral poliomyelitis vaccine, which has been the major biological tool making it possible to eradicate the wild type poliovirus.
1988年5月,世界卫生大会(WHA)年会促使世界卫生组织迎接在2000年全球根除脊髓灰质炎这一激动人心的挑战。基于一些已被证实的科学因素以及其他一些与野生脊髓灰质炎病毒传播相关的基本流行病学因素,全世界接受了这一挑战:1. 天花已被根除,沿用相同思路动员全球力量和投入来应对另一个全球威胁的机制依然可行;2. 泛美卫生组织(PAHO)在1985年5月前就已促使美洲地区在1990年根除脊髓灰质炎。尽管最初许多人对此举措持怀疑态度,但很快人们就认识到并记录到,泛美卫生组织开展的项目取得了高度成功,根除目标是可以实现的;3. 有利于开展根除行动的流行病学传播因素包括:a) 野生脊髓灰质炎病毒仅在人与人之间传播,没有野生动物宿主来维持其存在。b) 受感染个体要么死亡、致残,要么完全康复并保持免疫,多年内不会留存或携带病毒(不存在带菌状态)。c) 现有的疫苗,特别是口服脊髓灰质炎疫苗(OPV),不仅能够在个体中诱导长期免疫,还能通过在肠道内繁殖,排除或中断野生毒株的传播。世界卫生组织推荐并现已在全球采用的根除脊髓灰质炎的基本概念和策略非常简单:1. 每个国家的扩大免疫规划(EPI)将一岁以下儿童口服脊髓灰质炎疫苗的初次接种覆盖率常规提高到80%以上。在每个地区、每个省份的每个地方进行这样的免疫接种,麻痹性脊髓灰质炎的发病率会迅速降至极低水平。世界上大多数国家已经达到并超过了这一覆盖率水平。2. 每个国家开展国家免疫日(NIDs)活动,在此期间,无论之前的疫苗接种情况如何,给所有5岁以下儿童间隔一个月接种两剂口服脊髓灰质炎疫苗。这一策略增强了已接种疫苗儿童的免疫力,并覆盖了常规服务遗漏的儿童。野生脊髓灰质炎病毒在人体外无法长期存活,因此国家免疫日有效地阻断了野生脊髓灰质炎病毒的传播。中国能够在两天内为500多万名5岁以下儿童接种口服脊髓灰质炎疫苗。目前的做法是,许多邻国(有时多达15个)同时在2至3天内开展国家免疫日活动。3. 每个国家建立并运行一个极其灵敏的监测系统,能够检测到任何急性弛缓性麻痹(AFP)新病例。由于麻痹可能由其他病症引起,因此需要可靠的实验室服务作为现场监测的后盾,该服务能够从麻痹病例的粪便样本中分离出脊髓灰质炎病毒。然后,分离出的脊髓灰质炎病毒必须鉴定为野生型或疫苗型毒株。上述策略在世界所有国家均已启动,全世界已经见证急性弛缓性麻痹新病例急剧减少。根除脊髓灰质炎国际认证委员会已经制定了正式标准,据此可认证各国无脊髓灰质炎。一个地区的国家必须至少保持3年无脊髓灰质炎状态,该地区才能被认证为已根除野生脊髓灰质炎病毒。如果世界所有地区都得到认证,全球根除脊髓灰质炎的目标将得以实现。毫无疑问,全世界非常感谢所有那些国际组织,如国际扶轮社、世界卫生组织、联合国儿童基金会,以及发达国家的各国政府通过日本国际协力机构(JICA)、美国国际开发署(USAID)、丹麦国际开发署(DANIDA)等捐助机构,为实施根除脊髓灰质炎的扩大免疫规划调动了大量资源。这份感激之情也是对口服脊髓灰质炎疫苗的发现者阿尔伯特·萨宾博士的致敬,口服脊髓灰质炎疫苗是根除野生型脊髓灰质炎病毒的主要生物工具。